Inhibition of stimulus-triggered and spontaneous epileptiform activity in rat hippocampal slices by the Aconitum alkaloid mesaconitine

European Journal of Pharmacology

Volumn 342, Issue 2-3, 1998, Pages 183-191

  Ameri, Angela ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Epileptiform activity; Hippocampus; Mesaconitine

Indexed keywords

ACONITUM EXTRACT; ALKALOID DERIVATIVE; ALPHA ADRENERGIC RECEPTOR; MESACONITINE;

ANIMAL TISSUE; ANTICONVULSANT THERAPY; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; EPILEPSY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACONITINE; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTICONVULSANTS; BICUCULLINE; ELECTRIC STIMULATION; EPILEPSY; GABA ANTAGONISTS; HIPPOCAMPUS; MAGNESIUM; MALE; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; TIMOLOL; YOHIMBINE;

EID: 0032567751     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01498-2     Document Type: Article

References (28)

1. Ameri A., Shi Q., Aschoff J., Peters T. Electrophysiological effects of aconitine in rat hippocampal slice. Neuropharmacology. 35:1996;13-22.
2. Anderson W.W., Lewis D.V., Swartzwelder H.S., Wilson W.A. Magnesium-free medium activates seizure-like events in rat hippocampal slice. Brain Res. 398:1986;215-219.
3. Ault B., Wang C.M. Adenosine inhibits epileptiform activity arising in hippocampal area CA3. Br. J. Pharmacol. 87:1986;695-703.
4. Benn, M.H., Jacyno, J.M., 1983. The toxicology and pharmacology of diterpen alkaloids. In: Pelletier, S.W. (Ed.), Alkaloids - Chemical and Biological Perspectives. John Wiley and Sons, New York, pp. 153-210.
5. 3H -noradrenaline from adrenergic nerve of the vas deferens Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;621-630.
6. Bönisch H., Grafe K.H., Keller B. Tetrodotoxin-sensitive and -resistant effects of veratridine on the noradrenergic neurone of the rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 324:1983;264-270.
7. Campbell A., Holmes O. Bicuculline epileptogenesis in the rat. Brain Res. 323:1984;239-246.
8. Catterall W.A. Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Ann. Rev. Pharm. Toxicol. 20:1980;15-43.
9. Chagnac-Amitai Y., Connors B.W. Horizontal spread of synchronized activity in neocortex and its control by GABA-mediated inhibition. J. Neurophysiol. 61:1989;747-758.
10. Coan E.J., Collingridge G.L. Magnesium ions block a N-methyl-D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci. Let. 53:1985;21-26.
11. Dray A., Urban L., Dickenson A. Pharmacology of chronic pain. Trends Pharmacol. Sci. 15:1994;190-197.
12. 3H ]prazosin Brain Res. 672:1995;214-227.
13. Herron C.E., Williamson R., Collingridge G.L. A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci. Lett. 61:1985;255-260.
14. Isono T., Oyama T., Asami A., Suzuki Y., Hayakawa Y., Ikeda Y., Noguchi M., Omiya Y. The analgesic mechanism of processed aconiti tuber: Involvement of descending inhibitory system. Am. J. Chin. Med. 22:1994;83-94.
15. Loy R., Koziell D.A., Lindsey J.D., Moore R.Y. Noradrenergic innervation of the adult rat hippocampal formation. J. Comp. Neurol. 189:1980;699-710.
16. Mody I., Lambert J.D.C., Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J. Neurophysiol. 57:1987;869-888.
17. Mongeau R., Blier P., de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments. Brain Res. Rev. 23:1997;145-195.
18. Mueller A.L., Hoffer B.J., Dunwiddie T.V. Noradrenergic responses in rat hippocampus: Evidence for mediation by α and β receptors in the in vitro slice. Brain Res. 214:1981;113-126.
19. Mueller A.L., Palmer M.R., Hoffer B.J., Dunwiddie T.V. Hippocampal noradrenergic responses in vivo and in vitro. Characterization of alpha and beta components. Naunyn-Schmiedeberg's Arch. Pharmacol. 318:1982;259-266.
20. Olpe O.R., Laszo J., Pozza M.F., DeHerdt P., Waldmeier P.C., Jones R.S.G. Glutamate-induced activation of rat locus coerulus increases CA1 pyramidal cell excitability. Neurosci. Lett. 65:1986;11-16.
21. Raman I.M., Tong G., Jahr C.E. β-Adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron. 16:1996;415-421.
22. Sato H., Ohizumi Y., Hikino H. Mechanism of mesaconitine-induced contractile response in guinea pig vas deferens. Eur. J. Pharmacol. 55:1979;83-92.
23. Schmidt H., Schmitt O. Effect of aconitine on the sodium permeability of the node of Ranvier. Pflügers Arch. 349:1974;133-148.
24. 3H ]norepinephrine release by phencyclidine is dependent on potassium concentration Neuosci. Lett. 78:1987;333-337.
25. Stanton P.K., Mody I., Zigmond D., Sejnowski T., Heinemann U. Noradrenergic modulation of excitability in acute and chronic model epilepsies. Epilepsy Res. Suppl. 8:1992;321-334.
26. Tancredi V., Hwa G.G.C., Zona C., Brancati A., Avoli M. Low magnesium epileptogenesis in the rat hippocampal slice: Electrophysiological and pharmacological features. Brain Res. 511:1990;280-290.
27. Thomas M.J., Moody T.D., Makhinson M., O'Dell T.J. Activity-dependent β-adrenergic modulation oflow frequency stimulation induced LTP in the hippocampal CA1 region. Neuron. 17:1996;475-482.
28. 2-receptor-mediated inhibition of norepinephrine release at locus coeruleus synapses in dentate gyrus. J. Neurosci. 9:1989;2131-2140.